Select your language

Quality and efficacy specifically of solid oral dosage forms depend on the choice of the solid phase of the active ingredient (and excipients), the formulation design and the manufacturing process.

An important aspect of the relationship between dosage form processing and product quality is the potential for process-induced changes in the solid phase of the active ingredient during the manufacturing process.

Rational formulation and process designs therefore require an integrated knowledge of the solid-state properties of drugs, the active ingredient and its polymorphism, as well as the conversion mechanisms and available processing options. To ensure consistent product quality, it is essential to predict, control or prevent phase transformation during process design and development.

The Solid-State Detectives support you with all these requirements.